Login / Signup

Endocarditis caused by Aspergillus fumigatus in a patient 9 months after COVID-19 infection recovery: a case report and review of the literature.

Zeynab YassinShokoufeh HajsadeghiMohsen Taghavi ShavaziMahsa FattahiKoohyar AhmadzadehArmita FaridYeganeh KarimiFarnoosh SeirafianpourPegah BabaheidarianAzadeh Goodarzi
Published in: Journal of medical case reports (2023)
Aspergillus endocarditis should be considered in any patient with suspected endocarditis who has a history of COVID-19 infection and does not respond to routine antibiotic and antifungal therapy, as COVID-19 interferes with proper immune function, and lack of underlying cardiac conditions and immunodeficiencies does not preclude the diagnosis. Culture and histopathological evaluation of vegetations and emboli, as well as PCR, can confirm the diagnosis. Early initiation of antifungal therapy and surgical removal of infected valves and emboli can improve prognosis in patients with Aspergillus endocarditis.
Keyphrases
  • candida albicans
  • case report
  • coronavirus disease
  • sars cov
  • left ventricular
  • stem cells
  • heart failure
  • clinical practice
  • mesenchymal stem cells
  • atrial fibrillation